AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Apriglim-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Apriglim-M1 Tablet PR

Diabex Duo tablets are classified as antidiabetic medications, combining two active agents for adult type 2 diabetes management. This formulation aids in regulating blood glucose. Diabex Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication even if feeling well or with controlled blood sugar; discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat it. Maintain regular meals and carry a fast-acting glucose source like sweets or juice. Alcohol elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your physician of any history of heart conditions before commencing treatment; it may be unsuitable. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Apriglim-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Apriglim-M1 Tablet PR:

Follow your doctor's instructions or consult the product information leaflet for usage guidance. Administer Apriglim-M1 Tablet PR with a meal.

Common Side effects of Apriglim-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Apriglim-M1 Tablet PR:

Follow your physician's instructions or consult the product labeling for administration guidelines. Consume Apriglim-M1 Tablet PR with a meal.

How Apriglim-M1 Tablet PR works:

Apriglim-M1 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Apriglim-M1 Tablet PR ingestion is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Apriglim-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingUNSAFE

Using Apriglim-M1 Tablet PR while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Apriglim-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Apriglim-M1 Tablet PR is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Apriglim-M1 Tablet PR cautiously, potentially requiring dose modification. Consult a physician for guidance. A low initial dose of Apriglim-M1 Tablet PR is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Apriglim-M1 Tablet PR :

Should you forget a dose of Apriglim-M1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Apriglim-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglim-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and keep it out of reach of children, pets, and others.
Apriglim-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Apriglim-M1 Tablet PR and seek immediate medical attention.
Apriglim-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Apriglim-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Apriglim-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Apriglim-M1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Apriglim-M1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Apriglim-M1 Tablet PR
115
MRP 133
13% off